FORCI, BENEDETTA
 Distribuzione geografica
Continente #
NA - Nord America 763
EU - Europa 529
AS - Asia 200
AF - Africa 6
Totale 1.498
Nazione #
US - Stati Uniti d'America 760
RU - Federazione Russa 287
IE - Irlanda 70
CN - Cina 67
IT - Italia 59
SE - Svezia 48
PL - Polonia 44
HK - Hong Kong 40
SG - Singapore 32
JO - Giordania 29
IN - India 18
CI - Costa d'Avorio 6
GB - Regno Unito 6
CH - Svizzera 5
SA - Arabia Saudita 5
UA - Ucraina 5
IR - Iran 4
CA - Canada 3
DE - Germania 3
KR - Corea 3
FI - Finlandia 2
VN - Vietnam 2
Totale 1.498
Città #
Santa Clara 142
Fairfield 91
Dublin 70
Chandler 64
Ashburn 51
Warsaw 44
Woodbridge 36
Seattle 34
Beijing 28
Cambridge 28
Lawrence 28
Altamura 26
Hong Kong 26
Houston 24
Singapore 24
Wilmington 22
Princeton 19
Mumbai 17
Buffalo 14
Kent 14
Boston 13
Florence 13
Shanghai 11
San Diego 7
Abidjan 6
Dearborn 6
Medford 6
Ann Arbor 5
Bern 5
Moscow 5
Norwalk 5
Riyadh 5
New York 4
Guangzhou 3
Hefei 3
Seoul 3
Boardman 2
Dong Ket 2
Foggia 2
Forlì 2
Fuzhou 2
London 2
Redwood City 2
Rome 2
Toronto 2
Andover 1
Carate Brianza 1
Chengdu 1
Hebei 1
Hillsboro 1
Jiaxing 1
Jinan 1
Kunming 1
Lappeenranta 1
Los Angeles 1
Lucca 1
Montréal 1
Nanjing 1
Olbia 1
Redmond 1
Shenzhen 1
Wenzhou 1
Wuhan 1
Xi'an 1
Ürümqi 1
Totale 940
Nome #
Safety and efficacy of autologous hematopoietic stem cell transplantation following natalizumab discontinuation in aggressive Multiple Sclerosis. 131
Disease reactivation following fingolimod withdrawal in multiple sclerosis: Two case reports. 128
Bilateral isolated facial palsy with fast recovery in infectious mononucleosis 126
Clinical characteristics predicting relapses following disease modifying therapies discontinuation in multiple sclerosis: a monocentric cohort study 113
Severe disease reactivation in two multiple sclerosis patients after natalizumab withdrawal was not halted by monthly administrations of cyclophosphamide - two case reports 100
MRI analysis of the "central vein sign" allows identification of a subset of relapsing remitting MS patients with brain pathology different from inflammatory demyelination 92
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 82
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 80
Leptomeningeal enhancement analysis in diagnostic clinical setting 76
Comparative long term efficacy of beta interferons and azathioprine in relapsing-remitting Multiple sclerosis: single center retrospective 25 year evaluation 75
Autologous hematopoietic stem cell transplantation versus low-dose immunosuppression in secondary-progressive multiple sclerosis 72
Evaluation of dimethyl fumarate efficacy and safety in patients with relapsing remitting multiple sclerosis switching from other treatments 68
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 68
The Central Vein Sign identifies patients diagnosed with multiple sclerosis probably carrying different diseases and showing milder disease course 67
Real Life comparative evaluation of dimethyl fumarate efficacy and tolerability in relapsing remitting multiple sclerosis patients switching from other treatments 65
Incidence of malignant neoplasms and mortality in people affected by multiple sclerosis in the epoch of disease-modifying treatments: a population-based study on Tuscan residents 63
Sustained disease remission after discontinuation of disease modifying treatments in relapsing-remitting multiple sclerosis. 62
MS patients with low central vein sign frequency can be identified by FLAIR* MRi sequences 61
Totale 1.529
Categoria #
all - tutte 5.159
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.159


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020190 0 0 0 0 27 15 27 32 33 32 20 4
2020/202194 8 9 1 15 10 7 2 11 11 9 8 3
2021/2022110 2 8 6 7 1 5 5 13 6 4 17 36
2022/2023348 29 60 26 9 22 54 43 20 66 0 9 10
2023/2024145 5 15 18 8 18 11 3 30 1 4 22 10
2024/2025558 36 102 65 164 191 0 0 0 0 0 0 0
Totale 1.529